NeuroBo Pharmaceuticals to Participate in Investor Conferences in October

Provided By PR Newswire

Last update: Oct 1, 2024

CAMBRIDGE, Mass., Oct. 1, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that management will participate in the following investor conferences in October: